{
  "id": "641dc49b690f196b51000042",
  "type": "list",
  "question": "Treatment with plasma exchange (TPE) is used for what diseases",
  "ideal_answer": "Therapeutic plasma exchange (TPE) is the most common modality employed with the rationale of rapid reduction of a pathogenic substance distributed primarily in the intravascular compartment This includes cancer, infectious diseases like Dengue fever and Covid-19, septic shock and cytokine storm, and others such as Thrombotic thrombocytopenic purpura (TTP), diabetic ketoacidosis concomitant with type IX glycogen storage disease (GSD) and autoimmune disease of the CNS.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/35585996",
    "http://www.ncbi.nlm.nih.gov/pubmed/35551628",
    "http://www.ncbi.nlm.nih.gov/pubmed/28194064",
    "http://www.ncbi.nlm.nih.gov/pubmed/16382247",
    "http://www.ncbi.nlm.nih.gov/pubmed/34690074",
    "http://www.ncbi.nlm.nih.gov/pubmed/35955999",
    "http://www.ncbi.nlm.nih.gov/pubmed/29882008",
    "http://www.ncbi.nlm.nih.gov/pubmed/32802495",
    "http://www.ncbi.nlm.nih.gov/pubmed/35689538",
    "http://www.ncbi.nlm.nih.gov/pubmed/22277020",
    "http://www.ncbi.nlm.nih.gov/pubmed/10619926",
    "http://www.ncbi.nlm.nih.gov/pubmed/23619327",
    "http://www.ncbi.nlm.nih.gov/pubmed/23619323",
    "http://www.ncbi.nlm.nih.gov/pubmed/32605805",
    "http://www.ncbi.nlm.nih.gov/pubmed/34261138",
    "http://www.ncbi.nlm.nih.gov/pubmed/35353437",
    "http://www.ncbi.nlm.nih.gov/pubmed/35551087",
    "http://www.ncbi.nlm.nih.gov/pubmed/33884210",
    "http://www.ncbi.nlm.nih.gov/pubmed/1703815",
    "http://www.ncbi.nlm.nih.gov/pubmed/33991255",
    "http://www.ncbi.nlm.nih.gov/pubmed/35547461",
    "http://www.ncbi.nlm.nih.gov/pubmed/31029610",
    "http://www.ncbi.nlm.nih.gov/pubmed/30924130",
    "http://www.ncbi.nlm.nih.gov/pubmed/35963982",
    "http://www.ncbi.nlm.nih.gov/pubmed/34904748",
    "http://www.ncbi.nlm.nih.gov/pubmed/35302053",
    "http://www.ncbi.nlm.nih.gov/pubmed/17224307",
    "http://www.ncbi.nlm.nih.gov/pubmed/18331814",
    "http://www.ncbi.nlm.nih.gov/pubmed/24277990"
  ],
  "snippets": [
    {
      "text": "Therapeutic plasma exchange (TPE) is the most common modality employed with the rationale of rapid reduction of a pathogenic substance distributed primarily in the intravascular compartmen",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33991255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Though therapeutic apheresis modalities are employed frequently in children with kidney disease, most experiences are extrapolated from adult studies. International and national registries need to be established to elucidate the role of apheresis modalities in children with kidney disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33991255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551087",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Fulminant Hepatic Failure in Dengue Fever Without Plasma Leakage: A Case Report",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35547461",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551628",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, a randomized controlled trial (RCT) demonstrated rapid but individually variable hemodynamic improvement with therapeutic plasma exchange (TPE) in patients with septic shock.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551628",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombotic thrombocytopenic purpura (TTP) is becoming a curable disease with the introduction of therapeutic plasma exchange (TPE).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35689538",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Role of Therapeutic Plasmapheresis in SARS-CoV-2 Induced Cytokine Release Syndrome: A",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35585996",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Background: Cytokine release syndrome (CRS) significantly contributes to the pathophysiology and progression of COVID-19. It is speculated that therapeutic plasma exchange (TPE) can dampen CRS via elimination of pathogenic cytokines.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35585996",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Successful therapeutic plasma exchange in a case with extremely severe hypertriglyceridemia secondary to diabetic ketoacidosis concomitant with type IX glycogen storage diseas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34690074",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) is a treatment option to reduce thyroid hormones",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35963982",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "herapeutic plasma exchange in hyperthyroidism prior to surgery",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35963982",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35353437",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Optic neuritis (ON) causes several sequela. Aggressive treatment with plasma exchange (TPE) is an option",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35353437",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " We recruited adults with ON in neuromyelitis optica spectrum disorders (NMOSD) patients treated with TPE. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35353437",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Total Plasma Exchange in Neuromuscular Junction Disorders-",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35955999",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Total plasma exchange (TPE) has proven efficacy in NJD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35955999",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34904748",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) and immunoadsorption (IA) are first or second line treatment options in patients with neurological autoimmune diseases, including multiple sclerosis, neuromyelitis optica spectrum disorders (NMSOD), chronic inflammatory demyelinating polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barr\u00e9 syndrome), and autoimmune encephalitis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34904748",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) has been used for the treatment of neurologic diseases in which autoimmunity plays a major role.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17224307",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) has been used extensively for over 2 decades to treat a variety of autoimmune and congenital diseases and is now widely accepted.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10619926",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TPE is commonly used in neurological disorders where autoimmunity plays a major role.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28194064",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) is commonly used in many neurological disorders where an immune etiology was known or suspected.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18331814",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion; Therapeutic plasma exchange is an effective treatment option in several neurologic diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Therapeutic plasma exchange (TPE) is commonly used as treatment of certain autoimmune neurological diseases (ANDs), and its main objective is the removal of pathogenic a",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32802495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) is used in the treatment of neurological, hematological, renal and autoimmune diseases with known or suspected immune pathogenesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29882008",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TPE has an increasing list of indications in recent years such as neurological, connective tissue, hematological, nephrological, endocrinological and metabolic disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report our multicenter data about therapeutic plasma exchange in patients with neurological diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619327",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "TPE is an effective treatment in neurologic diseases in which autoimmunity plays an important role in pathogenesis, and it is safe when performed in experienced centers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17224307",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17224307",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) has been mainly used in the treatment of autoimmune diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30924130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TPE is useful in autoimmune haematological, renal, rheumatic and neurological diseases, and is recommended for acute disorders, together with relapsed or worsened chronic diseases that are often unresponsive to conventional treatments.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30924130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma exchange (TPE) is a treatment administered with the aim of removing a pathogenic material or compound causing morbidity in a variety of neurologic, hematologic, renal, and autoimmune diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33884210",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diseases that can be treated with TPE are classified into the following categories: (1) endocrinological, (2) neurological, (3) renal/rheumatological, and (4) haematological.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16382247",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Moreover, TPE in kidney diseases, for instance: desensitization in renal transplantation(ABO compatible) (living donor)and desensitization in deceased donor, desensitization in renal transplantation(ABO incompatible) (living donor), thrombotic microangiopathy complement Mediated (Factor H autoantibodies), Focal segmental glomerulosclerosis(recurrent in transplanted kidney), ANCA-associated rapidly progressive glomerulonephritis(Dialysis dependence, DAH), Anti-Glomerular basement membrane disease Goodpasture's syndrome)(DAH,Dialysis-independence,) has been utilized as an initial treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31029610",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " For decades, therapeutic plasma exchange (TPE) is performed for the management of immune-mediated diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34261138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therapeutic plasma-exchange (TPE) is used as primary and adjunctive therapy in treatment of several hematologic diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619323",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Successful treatment of aHUS with plasma infusions and therapeutic plasma exchange (TPE) is well reported.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24277990",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Several neurologic disorders have been treated with therapeutic plasma exchange (TPE).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22277020",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Therapeutic plasma exchange (TPE) is the first-line treatment for acute thrombotic thrombocytopenic purpura (TTP)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32605805",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TPE is effectively and safely carried out in our center in hematologic diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23619323",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Therapeutic plasma exchange (TPE) is a conventional second-line treatment for patients with multiple sclerosis (MS) or clinically isolated syndrome with steroid-refractory relapses",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35302053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As a supportive therapy, the plasma exchange was effective in the hyperviscosity syndrome, myasthenia gravis, thrombotic thrombocytopenic syndrome, myasthenia gravis, thrombotic thrombocytopenic purpura (TTP), hypercholesterolaemia, Guillain-Barr\u00e9 Syndrome, haemolytic crisis of a homozygous sickle-cell anaemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1703815",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "kidney disease, melanoma, cancer, dengue fever, Covid -19, septic shock, cytokine storm, diabetic ketoacidosis concomitant with type IX glycogen storage disease (GSD), neuromyelitis optica spectrum disorders., Neuromuscular junction disorders (NJDs), Guillain-Barr\u00e9 syndrome, auto immune, neurological disorders, hematological disorders, fulminant Hepatic failure, Newcastle Disease"
}